share_log

UroGen Pharma Ltd | 424B5: Prospectus

SEC ·  Jan 2, 2020 16:50
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more